EQUITY ALERT: Rosen Law Firm Announces Filing of Securities

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
410
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endologix, Inc. - ELGX

NEW YORK, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces that the filing of a class action lawsuit on behalf of purchasers of Endologix, Inc. securities (NASDAQ: ELGX ) from August 2, 2016 through November 16, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Endologix investors under the federal securities laws.

To join the Endologix class action, go to http://www.rosenlegal.com/cases-999.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Endologix did not have the requisite clinical data for FDA premarket approval of its Nellix® EndoVascular Aneurysm Sealing System; and (2) as a result, Endologix’s public statements were materially false and misleading at all relevant times. On November 16, 2016, Endologix announced that the FDA requested two-year follow-up data on patients enrolled in the EVAS-FORWARD-IDE study to assess Nellix. On this news, shares of Endologix fell $2.02 per share or over 20% to close at $7.82 per share on November 16, 2016, damaging investors.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 6, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-999.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com .

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling Preps for Q3 2026 Financial Results Call

Updated Category News Views 36

Anticipation Builds for Borr Drilling's Q3 Reveal Sit tight, investors. Borr Drilling Limited is set to drop its Q3 2026 financial results soon—right in the sweet spot post-market close on November 18. These moments are where fortunes are made or broken, and Borr's gearheads better be ready to spill the beans on how their offshore ventures fared in the rocky sea of...

Continue Reading
Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 63

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
Balancing Rigor and Interests in Education: Insights

Updated Category News Views 31

Education: A Balancing Act of Academics and Interests So here's the deal, folks. Education isn't just about hitting the textbooks and acing exams. It's a wild dance—balancing rigorous academics and the extracurricular hustle. Brent Reckman, the brains behind The Academy of Charter Schools in Westminster, Colorado, knows this orchestra well. In a feature with...

Continue Reading
Fitness Career Platform's Big Ramp Up Sparks Buzz

Updated Category News Views 66

ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...

Continue Reading
Common ADHD Accommodations Fail to Boost Performance

Updated Category News Views 34

Rethink ADHD Accommodations When it comes to ADHD, everyone ties the classic school accommodations to success. You give kids extra time, a quieter spot, and regular breaks, and you figure that's the magic formula, right? Well, hold onto your hats, because a fresh study out of Florida International University is flipping that script. Turns out, all those accommodations we...

Continue Reading
Monotype's Inkwell: A Type Family with New Twists

Updated Category News Views 31

Fresh Faces in the World of Type Out of the design trenches comes news that Monotype—the big cheese in type and tech—just rolled out four new styles in its well-liked Inkwell lineup. We're talking Inkwell Antique, Formal, Chancery, and Ornaments here. The idea? Give designers more room to play with tone. Let's chew on what this expansion means for folks rocking...

Continue Reading
Lavazza 2027 Calendar: Moments of Pleasure Worldwide

Updated Category News Views 114

Capturing Fleeting Joy Through the Lens In 2027, Lavazza sets the stage for an evocative exploration of human pleasure through its iconic calendar. Teaming up with photographers Jim Goldberg, Alex Majoli, and Paolo Pellegrin, the project spans three vibrant cities: New York, Lisbon, and Hong Kong. These masters of the lens invite us to pause and appreciate the understated...

Continue Reading
Azitra Reports Q3 2026: Key Developments in Biopharma Pipeline

Updated Category News Views 49

Unpacking Azitra's Recent Breakthroughs Azitra, Inc. galloped into the spotlight with their Q3 2026 financials and some hefty business updates. This isn’t just about dollars and cents; they've got some fascinating biotech news wrapped in. Riding High on ATR-COSF Ex Vivo Results All eyes are on Azitra’s ATR-COSF. The lab is lighting up with news — a 50% wrinkle...

Continue Reading
Global Energy Storage Colloquium Sparks Collaboration

Updated Category News Views 58

Setting the Stage for Energy Storage Breakthroughs Imagine a room bustling with brainpower, brimming with the promise of cleaner, more efficient energy. That's the scene at the inaugural Global Energy Storage Colloquium in Xiamen, where top-tier experts from all corners gathered to uncover what's next for energy storage. We're not just talking new gadgets but giant leaps...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 25

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading

Top 5 Most Recently Viewed Articles

Westhaven Gold Announces Leadership Changes and Operations Update

Updated Category News Views 329

Westhaven Gold Corporate Update VANCOUVER, British Columbia — Westhaven Gold Corp. (TSX-V: WHN) has recently announced a significant transition with the departure of Sean Thompson, the Vice President of Corporate Development & Investor Relations. This change marks a new chapter for the company as it continues to focus on its exploration and development activities....

Continue Reading
TerSera Discusses Game-Changing Findings on Goserelin for Breast Cancer

Updated Category News Views 122

TerSera Therapeutics made waves back in 2024 when it presented new data on goserelin, a drug that's been a game-changer for managing breast cancer, especially in younger patients. This wasn't just some routine announcement; it dropped at a major oncology symposium focused on quality care. You know how the market loves buzz around innovative treatments, and this one had...

Continue Reading
The Influence of Corporate Earnings on Stock Valuations

Updated Category Stocks Views 371

Introduction to the Link Between Corporate Earnings and Stock Valuations The important and significant connection between earnings and stock prices is often a concern for shareholders, analysts, and the economy. Corporate earnings are also known as the bottom line, net income, or profit and reflect a business entity’s financial status over a certain period. While on the...

Continue Reading
Hyster-Yale Reports Q3 2024 Financial Performance and Insights

Updated Category News Views 110

Financial Overview for Q3 2024 Hyster-Yale, Inc. (NYSE: HY) has reported solid financial results for Q3 2024, showcasing the company's resilience in navigating seasonal fluctuations. Despite the third quarter typically being slower, Hyster-Yale executed well, achieving a cash generation of $70 million from operations. Highlights from Q3 2024 The Q3 2024 financial...

Continue Reading
Time2Play Teams with Fabrizio Romano to Elevate Soccer

Updated Category News Views 13

Bringing European Soccer Insight to American Fans Suddenly we're talking soccer in the U.S. in a way that's making heads spin. It ain't like the old days when only a small bunch tuned in. Now, with Fabrizio Romano, the kingpin of transfer tidbits, hopping onboard Time2play, there's a different energy afoot. It's about time American fans get the scoop the Europeans have...

Continue Reading